Project Grant K08AI187716
Award Date
4/23/25
Completion Date
3/31/30
Dollars Obligated
$171K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Missouri, USA
Similar Awards
This $769,115 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will advance scientific understanding of how neurotropic viruses, including flaviviruses and alphaviruses, can directly enter the central nervous system (CNS) and cause severe illness. The principal investigators will explore the role of newly described meningeal structures, called arachnoid cuff exit (ACE) points, in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $197,366 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis to conduct research aimed at understanding the mechanisms by which the human immune system naturally restricts a specific subset of HIV, known as X4-tropic virus. The key goals of the 5-year research project are to: (1) characterize the molecular mechanisms driving the restriction of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a 5-year, $2,341,008 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis to investigate the role of stromal cell-mediated type I interferon signaling in alphavirus pathogenesis. The research project aims to utilize mouse genetics, temporal antibody blocking strategies, and RNA sequencing techniques to determine how type I interferons (IFNs) impact...
This $195,894 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis. The grant will fund a 5-year research project to study the mechanisms contributing to T cell dysregulation in STAT3 gain-of-function syndrome, a primary immune regulatory disorder. The research aims to gain a deeper understanding of critical interactions between T and B...
This Project Grant award, valued at $2,488,687, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to investigate the impact of gammaherpesvirus latency on host immune responses to subsequent pulmonary infections and the influence of the microbiome on viral latency establishment and maintenance. The principal investigator aims to define the role of viral latency on...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $46,715,173 Cooperative Agreement under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University to develop and optimize vaccine and monoclonal antibody-based treatments to rapidly respond to emerging flaviviruses and alphaviruses with pandemic potential. Key objectives include designing "plug and play" vaccine platforms that can be rapidly adapted to new viral threats,...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $737,502 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Washington University in St. Louis. The grant, titled "Role of WDFY4 in Treg Development," will fund research to investigate a novel pathway involving the WDFY4 protein that regulates antigen presentation by dendritic cells and is critical for the development and function of regulatory T cells (Tregs). The...
The University of Washington received a $2,556,480 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award will fund research to investigate the role of RIG-I-like receptors (RLRs) in triggering the innate immune response to West Nile virus (WNV) infection in myeloid cells. The research aims to define the specific WNV pathogen-associated molecular patterns (PAMPs) recognized...
This $188,980 Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research) aims to elucidate the role of intestinal M cells in rotavirus infection, systemic dissemination, and pathogenesis. Specifically, the research will determine the extraintestinal tissues and cell types targeted by rotavirus following oral inoculation, and use mouse models lacking intestinal M cells to study the role of these specialized cells in...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $125,160 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Ohio State University to characterize a novel bacterial immune system. The research aims to use cryo-electron microscopy and biochemical assays to define the structure and assembly mechanisms of a bacterial immune complex consisting of two components, A and B, which are predicted to have ATPase and nuclease functions,...